Assessment of risk perception of patients concerning adverse drug reactions
References
- EC. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmaco-vigilance. Directive 2001/83/EC on the Community code relating to medicinalproducts for human us. [http://eur-lex.europa. eu/LexUriServ/LexUriServ; 2010]
- World Health Organization. The importance of pharmacovigilance: safety monitoring of medicinal products. Geneva: WHO; 2002:1-48.
- Vilhelmsson A, Svensson T, Meeuwisse A, Carlsten A. Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association. BMC Pharmacol Toxicol. 2012;13(1):19.
- Herdeiro MT, Ferreira M, Ribeiro-Vaz I, Polónia JJ, Costa Pereira A. O Sistema Português de Farmacovigilância. Acta Med Port. 2012; 25(4).
- Matos C, van Hunsel F, Joaquim J. Are consumers ready to take part in the Pharmacovigilance System? - a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol. 2015;883-90.
- Matos C, Rodrigues L, Joaquim J. Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system. Drugs Ther Perspect. 2017;33(4).
- Matos C, Joaquim J, Pires T. Attitudes and knowledge of community pharmacy professionals regarding the spontaneous reporting of adverse drug reactions: a preliminary study in Coimbra, Portugal. Drugs Ther Perspect. 2017;33(2).
- Vallano A, Cereza G, Pedròs C, Agusti A, Danés I, Aguilera C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-8.
- Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi Pharm J. 2014;22(2):83-94.
- Aronson JK. Risk perception in drug therapy. Br J Clin Pharmacol. 2006;62(2):135-7.
- Alshakka MA, Ibrahim MIM, Hassali MAA. Do Health Professionals have Positive Perception Towards Consumer Reporting of Adverse Drug Reactions? J Clin Diagnostic Res. 2013;7(10):2181-5.
- Knapp P, Raynor DK, Berry DC. Comparison of two methods of presenting risk information to patients about the side effects of medicines. Qual Saf Heal Care. 2004;13(3):176-80.
- Paling J. Strategies to help patients understand risks. Br Med J. 2003;327(7417):745.
- Fukuda Y, Ando S, Saito M. Risk awareness, medication adherence, and driving behavior as determined by the provision of drug information to patients. Patient Educ Couns. 2020;103(8):1574-80.
- Britten N. Medication errors: the role of the patient. Br J Clin Pharmacol. 2009;67(6):646-50.
- Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff. 2007;26(3):731-40.
- Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362(10):865-9.
- Chinchilla K, Matos C, Hall V, van Hunsel F. Patient organizations’ barriers in pharmacovigilance and strategies to stimulate their participation. Drug Saf. 2021;44(2):181-91.
- van Hoof M, Chinchilla K, Härmark L, Matos C, Inácio P, van Hunsel F. Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis. Drug Saf. 2022;45(10):1083-98.
- Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148-56.
- Aishwaryalakshmi K, Sasikala B, Sreelalitha N, Vigneshwaran E, Reddy YP. Assessment of knowledge perception and attitudes on medications in general population. Editor BOARD. 2012;6.
- Jose J, Jimmy B, Al-Ghailani ASH, Al Majali MA. A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman. Saudi Pharm J. 2014;22(2):163-9.
- Cullen G, Kelly E, Murray FE. Patients’ knowledge of adverse reactions to current medications. Br J Clin Pharmacol. 2006;62(2): 232-6.
- Jatau AI, Shitu Z, Khalid GM, Yunusa I, Awaisu A. Understanding adverse drug-related emergency department visits: Development of a conceptual model through a systematic review. Ther Adv Drug Saf. 2019;10:1-18.
- Bongard V, Ménard-Taché S, Bagheri H, Kabiri K, Lapeyre-Mestre M, Montastruc JL. Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. Br J Clin Pharmacol. 2002;54(4):433-6.
- Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med (Northfield Il). 2016;16(5):481.
- Montastuc JL, Bongard V, Lapeyre-Mestre M. Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists. Eur J Clin Pharmacol. 2003;59(8-9):685-8.
- Ferrer RA, Klein WMP. Risk perceptions and health behavior. Curr Opin Psychol. 2015;5:85-9.
- Matos C, van Hunsel F, Tavares Ribeiro R, do Ó D, Raposo JF. Diabetes patient’s pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation. Ther Adv Drug Saf. 2020;11:2042098620953935.
- Robinson F, Wilkes S, Schaefer N, Goldstein M, Rice M, Gray J, et al. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community. Ther Adv Drug Saf. 2023;14:20420986221146416.
- Bahri P. Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies. Drug Saf. 2010;33:1065-79.
- Van Hunsel F, Passier A, Van Grootheest K. Comparing patients’ and healthcare professionals’ ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol. 2009;67(5): 558-64.
- Monteiro L, Monteiro-Soares M, Matos C, Ribeiro-Vaz I, Teixeira A, Martins C. Inappropriate prescriptions in older people – translation and adaptation to Portuguese of the STOPP/START screening tool. Int J Environ Res Public Health. 2022;19(11):6896.
Language: English
Page range: 103 - 107
Submitted on: Mar 5, 2023
Accepted on: Mar 20, 2023
Published online: Jun 30, 2023
Published in print: Jun 1, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Related subjects:
© 2023 João José Joaquim, Cristiano Matos, Ramona Mateos-Campos, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.